LLY
998.47
-0.25%↓
JNJ
244.74
-0.11%↓
ABBV
233.46
+0.78%↑
NVS
163.54
+1.89%↑
AZN
202.13
+2.34%↑
LLY
998.47
-0.25%↓
JNJ
244.74
-0.11%↓
ABBV
233.46
+0.78%↑
NVS
163.54
+1.89%↑
AZN
202.13
+2.34%↑
LLY
998.47
-0.25%↓
JNJ
244.74
-0.11%↓
ABBV
233.46
+0.78%↑
NVS
163.54
+1.89%↑
AZN
202.13
+2.34%↑
LLY
998.47
-0.25%↓
JNJ
244.74
-0.11%↓
ABBV
233.46
+0.78%↑
NVS
163.54
+1.89%↑
AZN
202.13
+2.34%↑
LLY
998.47
-0.25%↓
JNJ
244.74
-0.11%↓
ABBV
233.46
+0.78%↑
NVS
163.54
+1.89%↑
AZN
202.13
+2.34%↑
24 val.
Dabar
Min
3
Max
3.16
Rekomendacijos | Pirkti |
|---|---|
12 mėnesių prognozė | +415.15% upside |
Kitas uždarbis | 2026-03-27 |
|---|
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
2025-12-15 16:30; UTC
Fortress Biotech Rises After FDA Accepts Application for Menkes Treatment
DJ
Skaityti
2025-10-01 15:07; UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Skaityti
2025-03-10 02:12; UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Skaityti
2025-03-10 02:12; UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Skaityti
2025-03-10 02:11; UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Skaityti
2025-03-10 02:11; UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Skaityti
2025-03-10 02:10; UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Skaityti
2025-03-10 02:10; UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Skaityti
2025-03-10 02:06; UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Skaityti
Kainos pokytis
By TipRanks
12 mėnesių prognozė
Vidutinis 17 USD 415.15%
Aukščiausias 17 USD
Žemiausias 17 USD
Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Fortress Biotech Inc kainas – Dist per pastaruosius 3 mėnesius.
By TipRanks
Pirkti
1 ratings
1
Pirkti
0
Laikyti
0
Parduoti
Remiantis 1 analitikų, pateikusių Fortress Biotech Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.
$